ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,521 | -25.7% | 14,757 | -1.4% | 0.08% | -23.3% |
| Q2 2023 | $533,902 | +4.8% | 14,972 | -25.4% | 0.10% | -2.8% |
| Q1 2023 | $509,549 | -39.1% | 20,061 | -2.7% | 0.11% | -44.8% |
| Q4 2022 | $836,591 | -8.4% | 20,626 | -25.3% | 0.19% | -11.5% |
| Q3 2022 | $913,000 | -30.6% | 27,626 | -6.8% | 0.22% | -21.4% |
| Q2 2022 | $1,315,000 | -4.8% | 29,646 | -1.3% | 0.28% | -3.8% |
| Q1 2022 | $1,382,000 | -12.5% | 30,051 | +1.2% | 0.29% | -13.0% |
| Q4 2021 | $1,580,000 | -1.2% | 29,693 | +15.9% | 0.33% | -8.8% |
| Q3 2021 | $1,599,000 | +94.1% | 25,611 | +157.5% | 0.36% | +92.6% |
| Q2 2021 | $824,000 | +41.1% | 9,945 | +15.5% | 0.19% | +33.3% |
| Q1 2021 | $584,000 | – | 8,610 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |